Page 2 of 33 · 771 questions tagged coa.
Details up front: Janoshik · cagrilintide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
Conditions: 96.4% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
For reference: PeptideMeter · Chinese Peptide Company. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Stated plainly: VendorInvestigate · semaglutide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a…
Stated plainly: ERP · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints…
For reference: tirzepatide · 97.6%. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator because…
I am comparing three suppliers on documentation rather than on price. Everything I have found on this is either a forum aside or a product page, neither of which I…
The particulars: WWB · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The particulars: 96.4% · chromatogram. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Conditions: GL Biochem · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
The particulars: date of analysis · TFC. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I can parse the result. I am less sure what it licenses me to conclude. I have…
What I have: a GLP-1 receptor agonist · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
What I am working with: GL Biochem · an endotoxin test. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an…
The particulars: 99.4% · PeptideMeter · 98.2%. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup…
For reference: 98.2% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used to…
Numbers first: 99.1% · list of related substances. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Setup, so nobody has to ask: sampling plan · ERP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
For reference: 97.9% · PeptideMeter · 97.6%. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
Conditions: 99.1% · a C4 column · dulaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Concretely: 98.4% · VendorInvestigate · 96.4%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I want a method I can write down and repeat, not a rule of thumb. I would…
Setup, so nobody has to ask: HJ · an HPLC purity test. I want the working, not the result — I need to be able to redo it with different numbers. I care about the…
Conditions: WXT · mazdutide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the primary…